Europe Biohacking Market Size & Outlook, 2024-2030
Europe biohacking market, 2018-2030 (US$M)
Related Markets
Europe biohacking market highlights
- The Europe biohacking market generated a revenue of USD 7,648.6 million in 2024.
- The market is expected to grow at a CAGR of 18.2% from 2025 to 2030.
- In terms of segment, wearables was the largest revenue generating product in 2024.
- Mobile Apps is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 7,648.6 million |
| Market revenue in 2030 | USD 20,559.8 million |
| Growth rate | 18.2% (CAGR from 2025 to 2030) |
| Largest segment | Wearables |
| Fastest growing segment | Mobile Apps |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Wearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps |
| Key market players worldwide | Apple Inc, Fitbit, Harvey Norman Holdings Ltd, The ODIN, Thync, Moodmetric, Thriveport, TrackMyStack, OsteoStrong San Jose |
Other key industry trends
- In terms of revenue, Europe region accounted for 30.8% of the global biohacking market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 17,205.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biohacking Market Scope
Biohacking Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe biohacking market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biohacking market will help companies and investors design strategic landscapes.
Wearables was the largest segment with a revenue share of 34.63% in 2024. Horizon Databook has segmented the Europe biohacking market based on wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps covering the revenue growth of each sub-segment from 2018 to 2030.
Europe’s biohacking market is expanding due to a growing interest in personalized healthcare, advancements in synthetic biology, and increasing investments in neurotechnology. Countries across the region are emphasizing ethical research and regulatory compliance, balancing innovation with consumer safety.
Wearable biosensors, gut microbiome analysis, and nootropics are gaining traction among health-conscious individuals. The rise of government-supported biotech initiatives and collaborative research projects is also driving biohacking industry growth.
Reasons to subscribe to Europe biohacking market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe biohacking market databook
-
Our clientele includes a mix of biohacking market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biohacking market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biohacking market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe biohacking market size, by country, 2018-2030 (US$M)
Europe Biohacking Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
